For research use only. Not for therapeutic Use.
CB-25 is a ligand of CB1 cannabinoid receptors, acting as a partial agonist. CB-25 enhances Forskolin (HY-15371)-induced cAMP formation in cancer cells but not hCB1-CHO cells[1].
| Catalog Number | R033070 |
| CAS Number | 869376-63-6 |
| Synonyms | N-cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)undecanamide |
| Molecular Formula | C25H41NO3 |
| Purity | ≥95% |
| InChI | InChI=1S/C25H41NO3/c1-2-3-10-13-21-18-23(27)20-24(19-21)29-17-12-9-7-5-4-6-8-11-14-25(28)26-22-15-16-22/h18-20,22,27H,2-17H2,1H3,(H,26,28) |
| InChIKey | XFHZHCKWTBGPFD-UHFFFAOYSA-N |
| SMILES | CCCCCC1=CC(=CC(=C1)OCCCCCCCCCCC(=O)NC2CC2)O |
| Reference | [1]. Cascio MG, et al. In vitro and in vivo pharmacology of synthetic olivetol- or resorcinol-derived cannabinoid receptor ligands. Br J Pharmacol. 2006 Oct;149(4):431-40. |
